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Dear Editor,
Biomarkers represent an essential tool for identifi-
cation of patients developing infection and to deter-
mine their clinical severity. Procalcitonin (PCT)
levels appeared to be correlated with the develop-
ment of severe bacterial infections [1]. Thus, PCT
systematic use has been proposed as part of the
diagnostic tools and for monitoring treatment dur-
ation [2, 3], but not all of the potential benefits and
limitations of PCT have been investigated.
We retrospectively performed a case-control study
analyzing all patients with positive blood cultures
(BCs) in the period of January 2017 to December
2017 at a 1100-bed teaching hospital in Italy and
investigating the correlation between PCT and
C-reactive protein (CRP) values (± 24 h from BC col-
lection) in pathogens causing bloodstream infections.
The study flowchart is presented in Additional file 1:
Figure S1. During the study period, 1296 positive BCs
were retrieved; of these, 258 (19.9%) episodes were
recorded in the intensive care unit (ICU) and were
included in the study. Moreover, 213 patients hospi-
talized in ICU with negative BC were used as control.
Finally, 471 ICU patients were analyzed. Clinical charac-
teristic and outcome of patients, according to BC results,
are reported in Additional file 1: Table S1. As reported in
Fig. 1, PCT concentrations (in nanograms per milliliter)
were 25.1 ± 19.9 in patients with Gram-negative (GN)
etiology, 29.9 ± 13.2 for Enterobacteriaceae, 8.9 ± 7.5 for
Gram-positive (GP), and 2.1 ± 1.8 for fungi. Finally, in
Additional file 1: Figure S1, receiver operating characteris-
tic curves showed an area under the curve of 0.7 (95%
confidence interval (CI) 0.62–0.77, P < 0.001) for PCT and
0.45 (95% CI 0.37–0.54, P = 0.32) for CRP among GN iso-
lates, 0.74 (95% CI 0.67–0.81, P <0.001) for PCT and 0.49
(95% CI 0.4–0.57, P = 0.82) for CRP among Enterobacteri-
aceae, 0.46 (95% CI 0.39–0.53, P = 0.38) for PCT and 0.41
(95% CI 0.33–0.48, P = 0.01) for CRP among GP isolates,
and 0.64 (95% CI 0.46–0.83, P = 0.22) for PCT and
0.59 (95% CI 0.45–0.73, P = 0.43) for CRP among
fungi. Finally, logistic regression analysis showed that
PCT values of more than 0.5 ng/mL and more than
10 ng/mL were independently associated with BCs
positive for Enterobacteriaceae.
Our data confirmed the previous observations
about the role of PCT and CRP in predicting BC re-
sults in critically ill patients [4, 5]. Of interest, CRP
was not able to predict BC results, whereas PCT
values correlated with GN bacteremia and, among
them, specifically identified Enterobacteriaceae. High
PCT values (> 10 ng/mL) were independently associ-
ated with Enterobacteriaceae isolation. Even with
the limitation of a single-center experience, these
results might be useful to determine another role
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for PCT, helping physicians in the rapid identifica-
tion of bacteremic ICU patients at risk of GN infec-
tion (especially Enterobacteriaceae) and driving the
choice of a more appropriate empirical therapy.
Additional file
Additional file 1: Figure S1. Receiver operating characteristic curves
about procalcitonin (PCT) and C-reactive protein (CRP) to predict
blood cultures positive for Gram-negative (A), Enterobacteriaceae (B),
Gram-positive (C), and fungal (D) etiology. Table S1. Clinical characteristics
and outcome of patients according to etiology of infection. COPD chronic
obstructive pulmonary disease, CRP C-reactive protein, CVC central venous
catheter, ICU intensive care unit, ns not significant, PCT procalcitonin, SAPS
simplified acute physiology score, SD standard deviation, SSTI skin and soft
tissue infection. *Gram-positive etiology versus Gram-negative etiology.
#Gram-negative etiology versus fungal etiology. §Gram-positive etiology
versus fungal etiology. (DOC 435 kb)
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Fig. 1 Procalcitonin (PCT) concentrations (in nanograms per milliliter) in patients with Gram-negative, Enterobacteriaceae, Gram-positive, and
fungal etiologies. Abbreviation: SD standard deviation
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